Search

Your search keyword '"Massie, Barry M."' showing total 59 results

Search Constraints

Start Over You searched for: Author "Massie, Barry M." Remove constraint Author: "Massie, Barry M." Publisher ovid technologies (wolters kluwer health) Remove constraint Publisher: ovid technologies (wolters kluwer health)
59 results on '"Massie, Barry M."'

Search Results

2. Predictors of Postdischarge Outcomes From Information Acquired Shortly After Admission for Acute Heart Failure

3. Renal Function Trajectories and Clinical Outcomes in Acute Heart Failure

5. Benefit of Warfarin Compared With Aspirin in Patients With Heart Failure in Sinus Rhythm

6. Do Countries or Hospitals With Longer Hospital Stays for Acute Heart Failure Have Lower Readmission Rates?

8. Abstract 273: Incidence and Predictors of Heart Failure Hospitalization in Veterans Undergoing Cardioverter-Defibrillator Implantation in the Outcomes among Veterans with Implantable Defibrillators (OVID) Registry

12. Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction

13. Response to Letters Regarding Article, “Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction”

15. Impact of Serial Troponin Release on Outcomes in Patients With Acute Heart Failure

16. Relation of Peripheral Collagen Markers to Death and Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction

17. Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction

21. Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction

22. Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes

23. Response to Letter Regarding Article, “Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial”

24. Response to Letter Regarding Article, “Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial”

25. Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure

26. Prevention of Atrial Fibrillation

27. Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

30. Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia

31. Abstract 3640: Diabetes Mellitus is Associated with Increased Risk of Fatal and Non-Fatal Cardiovascular Events in Heart Failure Patients with Preserved Ejection Fraction - Findings From the Irbesartan in Heart Failure with Preserved Systolic Function Trial

32. Abstract 3148: Atrial Fibrillation Is Associated With Increased Risk Of Fatal And Non-fatal Cardiovascular Events In Patients With Heart Failure And Preserved Ejection Fraction - Findings From The Irbesartan In Heart Failure With Preserved Systolic Function Trial (I-PRESERVE)

33. Response to Letter Regarding Article, “Hemoglobin Level, Chronic Kidney Disease, and the Risks of Death and Hospitalization in Adults With Chronic Heart Failure: The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study”

35. Acute Heart Failure Syndromes

39. Improving Guideline Adherence

Catalog

Books, media, physical & digital resources